- Zogenix Acquires U.K.|Based Brabant Pharma🔍
- Zogenix Acquires Brabant Pharma in Up to $130M Deal🔍
- Zogenix Acquires Brabant Pharma in $35M Deal🔍
- Zogenix acquires U.K.|based Brabant Pharma🔍
- Zogenix Inc. has acquired Brabant Pharma🔍
- Zogenix Acquires Brabant Pharma Drug Lead For Dravet Syndrome🔍
- Zogenix acquires UK|based Brabant Pharma for up to $130 million🔍
- Brabant Pharma🔍
Zogenix acquires U.K.|based Brabant Pharma
Zogenix Acquires U.K.-Based Brabant Pharma | Fierce Biotech
SAN DIEGO, Calif., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. ... The acquisition includes worldwide development and commercialization rights ...
Zogenix Acquires Brabant Pharma in Up to $130M Deal
Zogenix, a pharmaceutical company focused on the treatment of pain-related and central nervous system disorders, acquired Brabant Pharma for $20 million in ...
Zogenix Acquires Brabant Pharma in $35M Deal - ProQuest
... acquired Brabant Pharma, a privately-held U.K.-based pharmaceutical company for $20 million in cash and $15 million in stock, plus potential future ...
Zogenix Acquires U.K.-Based Brabant Pharma - GlobeNewswire
The study is continuing today with fenfluramine sourced by Brabant Pharma, manufactured from a synthetic process consistent with current ...
Zogenix acquires U.K.-based Brabant Pharma | Drug Discovery News
Zogenix acquires U.K.-based Brabant Pharma. Obtains global rights for treatment option in development for Dravet syndrome, a rare and catastrophic form of ...
Zogenix Inc. has acquired Brabant Pharma - Global M&A Partners
Zogenix Inc. USA Based - Pharmaceutical Company Zogenix Acquires UK Bases Brabant Pharma for up to $130m. logo. Advisor : Zeus ...
On October 24, 2014, Zogenix Europe completed its acquisition of Brabant as described in Item 1.01, which description is incorporated herein by ...
Zogenix Acquires Brabant Pharma Drug Lead For Dravet Syndrome
Pharmaceutical company Zogenix announced that it has acquired U.K.-based Brabant Pharma along with global rights to Brabafen (low-dose ...
Zogenix Acquires Brabant Pharma in $35M Deal - San Diego ...
Zogenix Acquires Brabant Pharma in $35M Deal ... The acquisition includes worldwide development and commercialization rights to Brabafen, a treatment for Dravet ...
Zogenix acquires UK-based Brabant Pharma for up to $130 million
Zogenix acquires UK-based Brabant Pharma for up to $130 million.
(2) ZOGENIX, INC. (3) ZOGENIX EUROPE LIMITED. and. (4) BRABANT PHARMA LIMITED. AGREEMENT. for sale and purchase of. BRABANT ...
Brabant Pharma, Zogenix deal - BioCentury
In late October, Zogenix acquired Brabant for $20 million in cash and $15 million in stock, plus up to $50 million in regulatory milestone ...
... company's proposed acquisition of Zogenix. Such forward-looking ... These statements are based on Zogenix's current beliefs and expectations.
Zogenix, Inc. - Annual Reports
In October 2014, Zogenix Europe Limited, our wholly-owned subsidiary, acquired Brabant Pharma Limited, or Brabant, a privately-held company organized under ...
Brabant pharma - Crunchbase Company Profile & Funding
Based on the incidence of Dravet Syndrome, the new treatment will ... Brabant pharma acquired by Zogenix Logo. Brabant pharma acquired by Zogenix.
Zogenix - Recent News & Activity - Crunchbase
PR Newswire — UCB Completes Acquisition of Zogenix, Inc. News• Feb 28, 2022.
Zogenix acquires Brabant Pharma (a U.K.-based pharmaceutical company) and gains rights to global development and commercialization of Brabafen™ for the ...
an acquisition of Brabant Pharma, a privately-held U.K.-based pharmaceutical company. In March 2019, we entered into an exclusive.
Dr. Stephen Farr Appointed As CEO Of Zogenix (ZGNX) To Lead ...
... acquisition of Brabant Pharma. The transformational acquisition of ... These statements are based on the company's current beliefs and ...
Zogenix Announces Issuance of U.S. Patent for ZX008 in
... Brabant Pharma Limited, pursuant to a sale and purchase agreement with Brabant. ... These statements are based on the company's current beliefs and expectations.